1027 related articles for article (PubMed ID: 29621380)
21. Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors.
Franzoi MA; Vandeputte C; Eiger D; Caparica R; Brandão M; De Angelis C; Hendlisz A; Awada A; Piccart M; de Azambuja E
Breast Cancer Res Treat; 2020 May; 181(1):199-209. PubMed ID: 32246377
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients.
Cespedes Feliciano EM; Popuri K; Cobzas D; Baracos VE; Beg MF; Khan AD; Ma C; Chow V; Prado CM; Xiao J; Liu V; Chen WY; Meyerhardt J; Albers KB; Caan BJ
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1258-1269. PubMed ID: 32314543
[TBL] [Abstract][Full Text] [Related]
23. Change in Skeletal Muscle Following Resection of Stage I-III Colorectal Cancer is Predictive of Poor Survival: A Cohort Study.
Hopkins JJ; Reif R; Bigam D; Baracos VE; Eurich DT; Sawyer MM
World J Surg; 2019 Oct; 43(10):2518-2526. PubMed ID: 31222643
[TBL] [Abstract][Full Text] [Related]
24. Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.
Cespedes Feliciano EM; Lee VS; Prado CM; Meyerhardt JA; Alexeeff S; Kroenke CH; Xiao J; Castillo AL; Caan BJ
Cancer; 2017 Dec; 123(24):4868-4877. PubMed ID: 28881381
[TBL] [Abstract][Full Text] [Related]
25. The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: a population-based cohort study (C-SCANS).
Brown JC; Caan BJ; Meyerhardt JA; Weltzien E; Xiao J; Cespedes Feliciano EM; Kroenke CH; Castillo A; Kwan ML; Prado CM
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):664-672. PubMed ID: 29766660
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
[TBL] [Abstract][Full Text] [Related]
27. The association of body composition parameters and adverse events in women receiving chemotherapy for early breast cancer.
Aleixo GFP; Shachar SS; Deal AM; Nyrop KA; Muss HB; Chen YT; Yu H; Williams GR
Breast Cancer Res Treat; 2020 Aug; 182(3):631-642. PubMed ID: 32519169
[TBL] [Abstract][Full Text] [Related]
28. Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery.
Xiao J; Caan BJ; Cespedes Feliciano EM; Meyerhardt JA; Peng PD; Baracos VE; Lee VS; Ely S; Gologorsky RC; Weltzien E; Kroenke CH; Kwan ML; Alexeeff SE; Castillo AL; Prado CM
JAMA Surg; 2020 Oct; 155(10):942-949. PubMed ID: 32805015
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
[TBL] [Abstract][Full Text] [Related]
31. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
Lee J; Lin JB; Wu MH; Jan YT; Chang CL; Huang CY; Sun FJ; Chen YJ
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):814-826. PubMed ID: 31094101
[TBL] [Abstract][Full Text] [Related]
32. Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients.
Moon SW; Choi JS; Lee SH; Jung KS; Jung JY; Kang YA; Park MS; Kim YS; Chang J; Kim SY
Respir Res; 2019 Feb; 20(1):35. PubMed ID: 30767787
[TBL] [Abstract][Full Text] [Related]
33. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review.
Aleixo GFP; Williams GR; Nyrop KA; Muss HB; Shachar SS
Breast Cancer Res Treat; 2019 Oct; 177(3):569-579. PubMed ID: 31292800
[TBL] [Abstract][Full Text] [Related]
34. Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.
Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Jan YT; Hsu SM; Chen YJ
Clin Cancer Res; 2018 Oct; 24(20):5028-5036. PubMed ID: 29959140
[No Abstract] [Full Text] [Related]
35. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.
Cespedes Feliciano EM; Kwan ML; Kushi LH; Chen WY; Weltzien EK; Castillo AL; Sweeney C; Bernard PS; Caan BJ
Cancer; 2017 Jul; 123(13):2535-2542. PubMed ID: 28295245
[TBL] [Abstract][Full Text] [Related]
36. Skeletal muscle and visceral adipose radiodensities are pre-surgical, non-invasive markers of aggressive kidney cancer.
Furberg H; Bradshaw PT; Knezevic A; Olsson L; Petruzella S; Stein E; Paris M; Scott J; Akin O; Hakimi AA; Russo P; Sanchez A; Caan B; Mourtzakis M
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):726-734. PubMed ID: 38263932
[TBL] [Abstract][Full Text] [Related]
37. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer.
Griffin OM; Duggan SN; Ryan R; McDermott R; Geoghegan J; Conlon KC
Pancreatology; 2019 Sep; 19(6):850-857. PubMed ID: 31362865
[TBL] [Abstract][Full Text] [Related]
38. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer.
Tao J; Fang J; Chen L; Liang C; Chen B; Wang Z; Wu Y; Zhang J
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2591-2601. PubMed ID: 37724690
[TBL] [Abstract][Full Text] [Related]
39. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
[TBL] [Abstract][Full Text] [Related]
40. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]